Abstract: The present invention provides a serum-free culture medium for mammalian cells, especially non-adherent cells, containing a base medium, transferrin, insulin and selenite, wherein it contains or consists of2 to 10 mg./liter transferrin,2 to 10 mg./liter insulin,1 to 10 g./liter peptone,10 to 500 mg./liter beta-D-xylopyranose substituted with phosphate, carboxyl and/or sulphate groups,0.1 to 0.5 mg./liter selenite and0.1 to 2 mg./liter biological polyamine.

Abstract: Enrichment and purification of heart glycosides from mixtures of mother liquors is achieved by absorption on non-polar, large-pored resins from aqueous solution with possible addition of solvents miscible with water, and subsequent desorption with water/solvent mixtures or pure solvents.

Abstract: A tool for separating the two components of a modular joint prosthesis intended for implantation in a body. The prothesis includes a component adapted to be fixed to a long bone having an intramedullary canal and further includes an elongated male stem having a uniformly tapered outer surface. In order to accommodate the particular size of long bone to which the component is to be fixed, a properly sized female stem is attached to the male stem before the component is fixed to the long bone. The female stem is adapted to be received in the intramedullary canal for fixation thereto, and has a uniformly tapered inner surface, the angle of the taper being substantially similar to the angle of taper of the outer surface of the male stem. As a result, the male stem and female stem become locked together when the inner surface of the female stem engages the outer surface of the male stem.

Abstract: The present invention provides a process for the preparation of a specifically bindable protein substance bound to an insoluble carrier material, especially for use in a heterogeneous analysis process, wherein a soluable protein with a molecular weight above about 500,000, which is more hydrophobic than the specifically bindable substance, is coupled to the specifically bindable substance and then the conjugate of reaction component and protein is adsorbed on a hydrophobic solid phase.The present invention also provides a carrier material for use in solid phase immunoassays including a hydrophobic solid phase which is adsorbed on a conjugate of a hydrophobic protein with a molecular weight above about 500,000 and of a specifically bindable protein or protein containing substance.

Abstract: To prepare a microorganism producing .alpha.-galactosidase, not only a DNA containing an .alpha.-galactosidase gene but also a vector which is appropriate to the transformable cells to be used and contains antibiotic resistance genes are completely split with restriction endonuclease Sal I, the fragment of approximately four megadaltons of relative molecular weight is obtained from the fragments of the DNA containing the .alpha.-galactosidase gene, is mixed with the solution of the vector also split with Sal I, and is recombined in the presence of DNA ligase with the formation of a recombinant DNA.

Abstract: The present invention provides a dry reagent for blood coagulation tests in which an at least partial course of the coagulation cascade takes place, comprising a carrier material which contains a chromophoric substrate of a protease of the blood coagulation system, at least one factor and/or co-factor of the blood coagulation system and a buffer.

Abstract: Compounds of the formula I ##STR1## wherein R is a hydrogen atom or an alkyl radical, R.sub.1 is a hydrogen atom or an alkyl, alkenyl or a cycloalkyl radical, R.sub.2 is a hydrogen atom or an alkyl, alkenyl, alkylcarbonyl, alkoxycarbonyl, aminocarbonyl or hydrazinocarbonyl radical or R.sub.1 and R.sub.2, together with the carbon atom to which they are attached, form a cycloalkyl ring, X is a valency bond or an alkylene or vinylene radical, R.sub.3 is an aromatic heterocyclic five-membered ring containing 1 to 4 heteroatoms or pyridinyl which the five- and six-membered rings are optionaly substituted one or more times by alkyl, alkoxy, alkoxycarbonyl, carboxyl, alkylthio, hydroxyl, nitro, amino, halogen or cyano and the tautomers, optically-active forms and physiologically acceptable salts thereof with inorganic and organic acids.

Abstract: The present invention provides erythrocyte-retention substrates of the general formula:R.sub.1 --Sp--R.sub.2in which Sp is a bridge serving as a spacer, R.sub.1 is a strongly polar group and R.sub.2 is also a strongly polar group or, when Sp is an electron-conductive group, R.sub.2 can also be a polarizable group.The present invention also provides a process for the separation of erythrocytes from whole blood, wherein whole blood is brought into contact with one of the above substrates and subsequently filtered through a filter layer and the separated plasma obtained.

Abstract: A process for the determination of fructosamine in body fluids by the reaction of a sample solution with a color reagent, wherein the sample liquid is mixed with a buffer solution having a pH value of from 9 to 12, a color-forming reagent and uricase, as well as with at least one detergent, and the chronological change of the extinction is measured kinetically in a temperature range of from 20.degree. to 40.degree. C. at the earliest after 5 minutes.

Abstract: An apparatus is provided in combination with an instrument for determining the concentration of a medically significant component of a biologically fluid. The apparatus includes an integrated circuit carrier and a socket for removably longitudinally receiving the integrated circuit carrier. The socket includes a first set of electrical contacts and the integrated circuit carrier includes a second set of electrical contacts positioned and arranged so as to be electrically contacted by respective contacts of the first set of electrical contacts. One of the integrated circuit carrier and socket includes upstanding first wall portions extending generally along the longitudinal length of one of the integrated circuit carrier and socket and lying generally between adjacent electrical contacts of the first set.

Abstract: The present invention provides a plasmid suitable for the expression of penicillin G amidase, wherein it carries an incomplete penicillin G amidase gene in which the first 78 bases of the translated region on the 5' end of the complete gene are missing. This incomplete penicillin G amidase gene can also be present incorporated in the form of two separate fragments which commence with bases 79 and 868, respectively, counting from the translated region on the 5' end of the gene and displaying a deletion of the coding bases 705 to 867.The present invention also provides a process for the production of these plasmids and is also concerned with the use thereof for obtaining penicillin G amidase.

Abstract: A prosthetic acetabular cup assembly includes a single piece bearing component having an inner bearing surface for receiving a ball attached to a femoral prosthesis and an outer surface. The assembly also includes a shell component for attachment to an acetabulum to replace a natural hip socket includes an inner surface defining a cavity for receiving the bearing component therein. The inner surface of the shell component is formed to include an arcuate groove therein. A formed wire is situated in the arcuate groove of the shell component. The wire is configured so that a portion of the wire extends radially inwardly from the arcuate groove of the shell component to engage an arcuate groove formed in the bearing component to retain the bearing component inside the shell component.

Abstract: The present invention provides a process for the production of a polysaccharide matrix to which haptens are covalently bound, wherein polysaccharide-containing material is rendered alkaline, dried to a water content of less than 5% and then reacted in an anhydrous medium with a hapten containing at least one activated functional group.The present invention also provides a device for carrying out this process, which comprises a winding core (3) in a container (1) for a reaction solution which has a tube (11), provided on its wall with a plurality of openings (7) and closed on one end (9), for the reception of a winding (13) of the material to be treated and two axial end walls (15, 17) for sealing off the axial ends of the winding (13) and feeds the reaction solution from the container (1) into the other end (21) of the tube (11) by means of a circulating pump cycle (19).

Abstract: A method and apparatus for modifying the distal end of the humerus deformed by injury or disease in preparation for fixation of an elbow joint replacement. A through hole is first formed in the superior aspect of the olecranon fossa communicating with the humeral canal. A stem member which extends from the platform of a distal cut guide tool is received through the hole and extends into the humeral canal. The distal cut guide tool is held so that the platform is generally coplanar with the junction of the medial epicondyle and the trochlea with proper inclinations, both in an anterior view and in a lateral view. Thereupon, a first resected surface is formed by sawing, using as a guide, a planar guiding surface provided on the platform.

Abstract: The present invention provides pharmaceutical compositions effective against angina-like heart and circulatory diseases containing at least one nitroxyalkylamine derivative of the general formula: ##STR1## wherein R.sub.1 is a hydrogen atom, a lower-alkyl radical, a C.sub.3 -C.sub.8 -cycloalkyl or C.sub.3 -C.sub.8 -cycloalkenyl radical, an aminocarbonyl, C.sub.1 -C.sub.6 -mono- or di-alkylaminocarbonyl radical, R.sup.2 is a hydrogen atom, a lower-alkyl radical or a C.sub.3 -C.sub.8 -cycloalkyl or cycloalkenyl radical or R.sup.2, together with R.sup.1 and the nitrogen atom to which they are attached, form a heteroaliphatic ring containing up to 6 carbon atoms, A is a valency bond or a straight-chained or branched lower-alkylene radical, in which a --CH.sub.2 -- group can be replaced by a cycloalkylene radical, B is a lower-alkylene radical, in which a --CH.sub.2 -- group can be replaced by a cycloalkylene radical and X is an --NR.sup.3 --CO-- or --CO--NR.sup.3 -- radical, in which R.sup.

Abstract: The present invention provides a process for the determination of an analyte in a body fluid, in which there are used two binding components capable of specifically binding with one another, one of the binding components being enzyme-labelled and not carrier-fixed and the other binding component being carrier-fixed. The process contains a step in which the binding components are incubated with one another so that binding reaction takes place. The amount of enzyme-labelled binding component not bound to the carrier-fixed binding component is a measure of the concentration of the analyte which is determined by allowing the labelling enzyme to act upon a substrate producing a detection signal.

Abstract: The present invention provides compounds of the general formula: ##STR1## wherein R.sub.1 is a hydroxyl group or a methoxy radical, R.sub.2 is a hydrogen atom or a hyroxyl group and R.sub.3 is a hydrogen atom or a hydroxyl group, with the proviso that R.sub.2 and R.sub.3 are not simultaneously hydrogen atoms when R.sub.1 is a methoxy radical; and the pharmacologically acceptable salts thereof.The present invention also provides processes for the preparation of these compounds and pharmaceutical compositions containing them.

Abstract: The present invention provides a process for the detection of an analyte, wherein a sample containing the analyte is incubated either with a labelled binding partner and the immobilized analyte or an immobilized analyte analogue or with the labelled analyte or analyte analogue and an immobilized binding partner, the binding partner displaying towards the immobilized or labelled analyte or analyte analogue a higher affinity than towards the free analyte, and the labelled binding partner or the labelled analyte or the labelled analyte analogue is present in insufficiency compared with the concentration of the analyte to be detected.

Abstract: The present invention provides sulphonamides of the general formula: ##STR1## wherein R is a hydrogen or halogen arom, a cyano group or a C.sub.1 -C.sub.6 -alkyl or trifluoromethyl radical, n is 1, 2 or 3, m is 0 or 1 to 5, X is a valency bond, an oxygen atom, a carbonyl group or a --CHOH-- group, A is a valency bond or a carbonyl group and B is a valency bond or an --NH-- group; the physiologically acceptable salts thereof with inorganic and organic acids, as well as the optical isomers thereof.The present invention also provides processes for the preparation of these compounds and pharmaceutical compositions containing them.

Abstract: An analytical system for the determination of a component of a fluid, especially blood or urine, is disclosed. It comprises test carriers, which have at least one test field, and an evaluating instrument for the measurement of a characteristic change in the test field.In order to achieve rapid and selective heating of individual test fields, especially in test carriers that are multiple-test strips, the corresponding test field has a metallic conducting layer, which runs parallel to the test field and is in thermal contact with it. The evaluating instrument has an induction heater. The guiding mechanism of the test carrier in the evaluating instrument is designed so that the metallic conducting layer, at least before the measurement, is in the working area of the alternating magnetic field emanating from the induction heater.